Pfizer
Tuesday, January 31, 2012 Pfizer
Click on the link to see more recent Pfizer news
12:13 :
Pfizer Profits Halved As Lipitor Comes Off Patent -
Pfizer booked a sharp decline in fourth-quarter profit Tuesday, and more importantly cut its 2012 outlook as it projects its first year of results after patent expiration on cholesterol drug Lipitor.
11:05 :
Generics take toll on Pfizer, Lilly profits -
(Reuters) - Competition from low-cost generic drugs squeezed quarterly profits at Pfizer Inc and
Eli Lilly & Co but the drugmakers were able to somewhat weather those declines with help from other medicines.
10:11 :
Pfizer 4Q Revenues Down, Profits Still Up -
Pfizer remained profitable despite a reported drop in quarterly earnings, beating analysts' dire predictions of lost revenue to generic versions of its best-selling drug Lipitor through its non-pharmaceutical units and cost cutting.
08:48 :
Pfizer trims 2012 view, citing stronger dollar -
(Reuters) - Pfizer Inc reported sharply lower quarterly earnings, hurt by generic forms of its Lipitor cholesterol drug, and the company trimmed its 2012 forecasts due to negative effects of the stronger dollar.
08:18 :
Pfizer, Lilly Profit Slumps -
Pfizer's profit fell 50% on one-time charges and a drop in U.S. revenue, which was hurt by cholesterol drug Lipitor losing patent protection. Eli Lilly's net income tumbled 27% on the loss of a patent protecting its top-seller Zyprexa.
07:31 :
Pfizer posts lower profit, lowers outlook -
LONDON (MarketWatch) -- Pfizer Inc. on Tuesday reported a fourth-quarter profit of $1.44 billion, or 19 cents a share, down from $2.89 billion, or 36 cents a share, a year earlier. Sales dipped to $16.75 billion from $17.35 billion a year ...
acciones Pfizer -